Apr 18, 2024
Press communication Lund, Sweden, April 18, 2024 This is a translation of the Swedish press release published 2024-04-18 Neola Medical AB (publ) has completed the Human Factors Validation Study with Neola®, the company’s medical device for continuous lung...
Mar 28, 2024
Press communication Lund, Sweden, March 28, 2024 This is a translation of the Swedish press release published 2024-03-28 Neola Medical’s product for lung monitoring of preterm born infants, Neola®, was selected by Stanford as one of the top ten most promising...
Mar 20, 2024
Press communication Lund, Sweden, March 20, 2024 This is a translation of the Swedish press release published 2024-03-20 The initial months of 2024 continue with intensive work and positive progress for Neola Medical in preparation for upcoming studies for market...
Feb 29, 2024
Press communication Lund, Sweden, February 29 This is a translation of the Swedish press release published 2024-02-29, 07.00 CET Neola Medical AB (publ) will commence a Human Factors Validation Study in March 2024 with Neola®, the company’s medical device for...
Feb 5, 2024
Press communication Lund, Sweden, 5 February 2024 This is a translation of the Swedish press release published 2024-02-05 Neola Medical AB (publ) invites to presentation of the Q4-report of 2023, Wednesday the 14th of February 2024 at 11am CET (11.00). The...
Jan 8, 2024
Press communication Lund, Sweden, January 8 2024 This is a translation of the Swedish press release published 2024-01-08 Neola Medical AB (publ) will be present at the investor conference J.P. Morgan Healthcare Conference in San Francisco in January 2024. CEO Hanna...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy